ALFA FinderBSE filing, NSE: TRIMURTHI. Summary written from the filing by ALFA Finder's alert engine.
Novelix Pharmaceuticals Ltd: key numbers
- Share price
- ₹71.00
- Market cap
- ₹125.1 Cr
- Revenue (annual)
- ₹132.3 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 26.9×Sector 66.2×
- Promoter holding
- 54.29%+3.72% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novelix Pharmaceuticals Ltd
All →Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals reported no deviation in its July 2026 fund raise utilisation for the September quarter. This periodic statement records no new business event.
Novelix Pharmaceuticals Q2 FY27 Results: Net Profit ₹1.6 Cr, Up 220.0% YoY
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹44.7 Cr (+22.8% YoY) and net profit of ₹1.6 Cr (+220.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.6 Cr · +220.0% YoY
Novelix Pharmaceuticals Board Meeting Date
Novelix Pharmaceuticals has given prior intimation of a board meeting on 11 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until forty-eight hours after the meeting.
Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals Ltd has filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Novelix Pharmaceuticals Management Change
Novelix Pharmaceuticals announced the appointment of Mr. Gnana Prakash Gattu as Whole Time Director, approved by shareholders at the company's 32nd Annual General Meeting.
Novelix Pharmaceuticals Annual General Meeting
Novelix Pharmaceuticals held its 32nd Annual General Meeting on 30th September, 2026, transacting ordinary and special business items via e-voting and video conferencing.
Other management change announcements
All →Tera Software Management Change
Tera Software appointed Mr. G. Venkatanarayana as Chief Financial Officer and KMP effective December 4, 2026, filling the vacancy from Anilkumar's resignation. The CFO change is a senior management appointment.
Richfield Financial Services Management Change
Richfield Financial Services disclosed the resignation of its Company Secretary and Compliance Officer, effective 2 December 2026. A replacement is sought and will be notified once filled.
Prima Industries Management Change
Prima Industries appointed Mr. Kushagra Gupta as Managing Director for five years from 12 November 2026, filling a vacancy after the Chairman and MD's demise. Shareholder approval is still pending.
- Execution
- 5 years from 12 November 2026
V B Desai Financial Services Management Change
V.B. Desai Financial Services disclosed the resignation of non-independent director Rachana Shashank Vijayakar effective November 12, 2026, citing personal commitments. Annexure I and her resignation letter are enclosed.
Dolfin Rubbers Management Change
Dolfin Rubbers Limited disclosed the resignation of Independent Director Yashul Goyal, effective 12 November 2026, citing pre-occupation. The company confirmed no other material reasons for the resignation.
Rashtriya Chemicals & Fertilizers Management Change
Rashtriya Chemicals extended Nazhat Shaikh's tenure as Director (Finance) and CFO until March 31, 2027. Two firms were also appointed as internal auditors.
- Execution
- December 1, 2026 to March 31, 2027, or until further orders, whichever is earlier